DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for p24 assay are 9

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_6568	Saquinavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved, Investigational	20810732
DrugRepV_6569	Amprenavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved	20810732
DrugRepV_6570	Indinavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved	20810732
DrugRepV_6571	Nelfinavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved	20810732
DrugRepV_6572	Ritonavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved, Investigational	20810732
DrugRepV_6573	Lopinavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved	20810732
DrugRepV_6574	Atazanavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved	20810732
DrugRepV_6575	Tipranavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved, Investigational	20810732
DrugRepV_6576	Darunavir	Antiinfectives For Systemic Use	Acquired immunodeficiency syndrome	Human immunodeficiency virus	HIV-1ERS104pre		p24 assay	Decrease (50 %)	Approved	20810732